The probiotic Bacillus subtilis BS50 decreases gastrointestinal symptoms in healthy adults: a randomized, double-blind, placebo-controlled trial.

Garvey SM, Mah E, Blonquist TM, Kaden VN, Spears JL

Open source

DOI
10.1080/19490976.2022.2122668
Published
2022 Jan-Dec
Container
Gut microbes
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/19490976.2022.2122668,
  title = {The probiotic Bacillus subtilis BS50 decreases gastrointestinal symptoms in healthy adults: a randomized, double-blind, placebo-controlled trial.},
  author = {Garvey SM and Mah E and Blonquist TM and Kaden VN and Spears JL},
  year = {2022},
  journal = {Gut microbes},
  doi = {10.1080/19490976.2022.2122668},
  url = {https://doi.org/10.1080/19490976.2022.2122668}
}

RIS

TY  - JOUR
TI  - The probiotic Bacillus subtilis BS50 decreases gastrointestinal symptoms in healthy adults: a randomized, double-blind, placebo-controlled trial.
AU  - Garvey SM
AU  - Mah E
AU  - Blonquist TM
AU  - Kaden VN
AU  - Spears JL
PY  - 2022
JO  - Gut microbes
DO  - 10.1080/19490976.2022.2122668
UR  - https://doi.org/10.1080/19490976.2022.2122668
ER  - 

APA

SM, G., E, M., TM, B., VN, K., & JL, S. (2022). The probiotic Bacillus subtilis BS50 decreases gastrointestinal symptoms in healthy adults: a randomized, double-blind, placebo-controlled trial.. Gut microbes. https://doi.org/10.1080/19490976.2022.2122668

Source records